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Abstract
Introduction Imbalance in autonomic cardiovascular function increases the risk for sudden death in
patients with coronary artery disease (CAD), but the time course of the impact of coronary artery
bypass grafting (CABG) on autonomic function has been little studied. Thus, the purpose of the
present study was to determine the effects of the CABG on the cardiovascular autonomic function.
Methods Patients undergoing CABG (n = 13) and two matched control groups (patients with CAD
who refused surgical treatment [n = 9], and healthy volunteers [n = 9]) underwent a prospective
longitudinal study consisting of autonomic evaluation before and after (3, 6, 15, 30, 60, and 90 days)
surgery, including measurement of heart rate variability (HRV), respiratory sinus arrhythmia (RSA), and
Valsalva maneuver.
Results After CABG there was a decrease in, and a later recovery of, (1) the HRV in the time domain
and in the frequency domain, (2) RSA, and (3) Valsalva maneuver.
Conclusions CABG caused an impairment, reversible after 60 days, of cardiovascular autonomic
function, with a maximal decrease on about the sixth day after surgery.
Introduction
Imbalance in autonomic cardiovascular function has been
shown to increase the risk for ventricular arrhythmias and sud-
den death in patients with coronary artery disease (CAD) and
after myocardial infarction [1,2]. Under these conditions there
is an increased sympathetic adrenergic tone and reduced par-
asympathetic activity [3], a combination that causes aug-
mented ventricular workload and oxygen demand, increasing
the occurrence of ischemic events, and causes modification of
the ionic currents across the cellular membrane, leading to
direct electrical instability of myocytes.
The autonomic cardiovascular function has been traditionally
evaluated by bedside tests such as respiratory sinus arrhyth-
mia (RSA) and Valsalva maneuver, which measure the blood
pressure and heart responses to standard stimuli [4,5]. In the
past two decades, quantification of heart rate variability (HRV)
has been used as an indicator of the autonomic control of
sinus rate [6], providing independent predictive power for sud-
den death and all-cause mortality in CAD [1,2]. The signals
necessary for HRV analysis can be obtained from electrocar-
diogram tracings recorded from short (15 min) resting periods
to an entire day (24 hours) with multiple moments of physical
activity. The HRV profile can be expressed both in the time
domain, by measures of the variations in the R–R interval dura-
tions, and in the frequency domain, through spectral analysis
[6].
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Myocardial revascularization by coronary artery bypass graft-
ing surgery (CABG) is an effective measure for reducing the
symptoms and mortality in patients with unstable or severe
CAD [7,8]. Despite the increasing importance of autonomic
cardiac function for risk stratification in heart disease and, in
contrast, the positive clinical outcome of CABG, there have
been only few longitudinal studies investigating the impact of
CABG on cardiac autonomic function. Although previous
studies have indicated a diminished autonomic function after
CABG [9-13], they could not describe properly the profile of
cardiac autonomic function after surgery because they either
lacked higher resolution in the first weeks after CABG or did
not follow the patients up long enough to detect full recovery
of cardiac autonomic indexes after CABG. The purpose of this
study was therefore to evaluate, noninvasively and repeatedly,
the cardiovascular autonomic function of patients with CAD
during the initial three months after CABG, starting with a pre-
surgery evaluation and repeated 3, 6, 15, 30, 60 and 90 days
after surgery. Results obtained were compared with those
from two control groups: matched patients with CAD but not
undergoing CABG, and matched healthy volunteers.
Methods
Subjects
Thirteen patients (five female, eight male) undergoing CABG
were recruited from the Procordis Hospital, Niterói, RJ, Brazil,
fulfilling the following inclusion criteria: subjects of either sex,
with diagnosed CAD (including laboratory tests, such as elec-
trocardiogram, stress test, or coronary angiogram) and clinical
indication for CABG. The exclusion criteria were as follows:
presence of diabetes mellitus, congestive heart failure, previ-
ous cardiac surgery, recent (less than 6 months) myocardial
infarction, implanted cardiac pacemaker, presence of atrial
fibrillation, use of intraortic balloon, use of mechanical ventila-
tion for more than 24 hours after surgery, myocardial infarction
after surgery, and any other condition that could affect the
autonomic function.
A control group (CAD; n = 9; five females, four males) for the
surgical intervention was selected and paired by age and
number of coronary vessels compromised (defined angio-
graphically as more than 50% lumen obstruction). These
patients also had clinical indication for CABG but refused to
undergo surgery.
A further control group (healthy; n  = 9; four females, five
males) was included to evaluate the effect of CAD on auto-
nomic function. The volunteers of this second control group
were paired by age and the inclusion criteria for this group
were to be asymptomatic and to have physiological responses
to an exercise test without myocardial ischemia. The present
study therefore employed two different groups as controls,
one with patients with CABG who refused to undergo surgery
and another consisting of healthy adults.
Procedures
All subjects were informed with details about the protocol,
which had been approved by the Institutional Review Board,
and signed an informed consent form to participate in the
study. They were instructed not to exercise or to take alcoholic
or caffeinated drinks on the experimental days. All subjects
were trained to perform autonomic tests with acceptable tech-
nical quality before actual measurements were made. Heart
rate was recorded with a digital system for telemetry consist-
ing of a transmitter placed on the subject's chest and a recep-
tor and interface connected to a personal computer (Polar
Vantage; Polar Electro Oy, Kempele, Finland). This system
detects ventricular depolarization, corresponding to the R
wave on the electrocardiogram, with a sampling rate of 500 Hz
and a temporal resolution of 1 ms [14], and has been validated
previously against standard Holter electrocardiography [15].
The patients in the CABG group were evaluated on the day
preceding surgery and 3, 6, 15, 30, 60, and 90 days after sur-
gery. The patients in the CAD group were tested four times in
3 months (0, 30, 60, and 90 days) and the volunteers in the
healthy group were tested once.
Respiratory sinus arrhythmia
After resting in the supine position for 15 min, the subjects
were trained to perform respiratory cycles lasting 10–12 s,
changing lung volume from maximal expiration (residual vol-
ume) to maximal inspiration (total lung capacity). The heart rate
response to the RSA test was measured by the expiration/
inspiration index (E/I index), calculated as the ratio between
the longest R–R interval during expiration and the shortest R–
R interval during inspiration.
Valsalva maneuver
Shortly after resting for 15 min in sitting position, the subjects
blew into a closed system connected to an aneroid manome-
ter, exerting an expiratory pressure of 40 mmHg for 15 s, fol-
lowed by expiration and spontaneous breathing. The Valsalva
index was calculated by the ratio between the longest R–R
interval after releasing the pressure and the shortest R–R
interval during the forced expiratory pressure.
Heart rate variability
The subjects rested for 10 min after the autonomic tests in the
supine position and started a 15 min period of paced breath-
ing at 18 cycles/min (0.30 Hz) and spontaneous tidal volume.
The respiratory rate was kept constant with the aid of a
metronome.
The original series of R–R intervals were filtered by a semi-
automatic method [6], keeping the original time reference. The
following parameters of HRV in the time domain were calcu-
lated: the standard deviation of all R–R intervals; the standard
deviation of the averages of the R–R intervals calculated in 5
min segments; the percentage number of pairs of adjacent R–Available online http://ccforum.com/content/9/2/R124
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R intervals differing by more than 50 ms; and the square root
of the mean of squares of differences between adjacent R–R
intervals (RMSSD).
For frequency-domain analysis, the filtered R–R series were
subjected to a cubic spline interpolation and decimated to be
equally spaced in time. The decimated time series were used
to calculate the power spectrum, calculated by the fast Fourier
transform. The following parameters were analyzed: total
power, power in the low-frequency (LF, 0.08–0.15 Hz) and
high-frequency (HF, 0.15–0.40 Hz) bands, and the LF/HF
ratio.
Respiratory function
Forced expiratory vital capacity was measured (Spirodoc; Mir,
Rome, Italy) before the autonomic tests. The expiratory maneu-
vers were performed after full inspiration (total lung capacity)
in the seated position and repeated three times, taking the
best result for analysis. Another series of forced expiratory
maneuvers after full inspiration were used to measure the
patient's peak expiratory pressure by manovacuometry (GEAR
07-01, Instrumentation Inc., Springfield, IL, USA). For this eval-
uation, the subjects were instructed to produce the effort with
the chest and abdominal muscles and to keep the expiratory
pressure for 3 s. The best result of three consecutive maneu-
vers was used for analysis.
Statistical analysis
The patients' characteristics were compared by one-way anal-
ysis of variance (ANOVA) for the continuous variables or by
Fisher's exact test for the proportions. Data from the auto-
nomic evaluations were compared by a two-way ANOVA for
repeated measures in which group (CABG, CAD, or healthy)
and time were the main factors. The Bonferroni test was used
for post-hoc pairwise analysis. Student's t-test was used to
compare the results from patients with or without previous
myocardial infarction within the CABG and CAD groups. The
minimum necessary sample size was determined by setting
the statistical power to 0.8 and the alpha error to 0.5. On the
basis of the results of the R–R interval from pilot experiments
and previous experience with patients undergoing CABG, we
considered the minimum detectable difference to be 80 ms
and the expected standard deviation of residuals as 50 ms for
the ANOVA with three groups, yielding a sample size of nine
subjects. All statistical procedures were performed on the Sig-
maStat® (Jandel Scientific, San Rafael, CA, USA) and statisti-
cal significance was accepted at P < 0.05.
Results
The results of the autonomic evaluation in patients with or with-
out previous myocardial infarction in the CABG group (n = 5
and n = 8, respectively) and in the CAD group (n = 2 and n =
7, respectively) were similar. The data were therefore pooled
within each group. The patients' characteristics are presented
in Table 1. Note that gender proportion, age, body mass index
and drugs used were not statistically different between
groups.
Respiratory sinus arrhythmia and Valsalva maneuver
The indexes obtained during Valsalva maneuver and RSA pre-
sented a similar time profile in the CABG group. This profile
was characterized by a marked decrease 3 days after surgery,
followed by a significant increase after 15 days and a recovery
to values similar to those observed before surgery after 30
days. Valsalva and RSA indexes in the CAD group were com-
parable to those observed in the CABG before surgery, and
they did not change during the 90 days afterwards. Results for
Table 1
Demographic characteristics of patients and control subjects
Characteristic CABG (n = 13) CAD (n = 9) Healthy (n = 9)
Sex (males/females) 8/5 5/4 4/5
Age (years) 64 ± 2 64 ± 2 63 ± 2
Body mass index (kg/m2) 27.6 ± 0.6 27.4 ± 0.7 26.5 ± 0.9
Drug used
ACE inhibitors/AngioII-blockers 5 6 -
Digital 3 0 -
Anti-arrhythmic 1 0 -
β-blockers 6 1 -
Calcium-channel antagonists 4 1 -
AAS 7 3 -
Values are means ± SEM. AAS, acetylsalicylic acid; ACE, angiotensin-converting enzyme; CABG, patients who underwent coronary artery bypass 
grafting; CAD, patients with coronary artery disease who did not undergo surgery; healthy, control subjects without CAD. The three groups were 
similar with regard to all variables (P > 0.05).Critical Care    April 2005  Vol 9 No 2    Soares et al.
R127
the healthy group were higher than those for the CABG and
CAD groups (Fig. 1).
Heart rate variability
The time-domain indexes of HRV decreased after CABG,
returning to pre-surgery values by 30 or 60 days after surgery
(Table 2). The values for the CAD group were similar to those
from the CABG pre-surgery evaluation, whereas all values in
the healthy group were higher than those for the CAD and
CABG groups, except for the mean R–R interval and RMSSD.
Spectral analysis of HRV showed a similar change for total
power when compared with the time-domain indexes; that is,
a decrease in the first evaluation after CABG, a relative
increase at 15 days, and a return to pre-surgery values at 60
days. The CAD and CABG groups presented similar values for
this variable at the pre-surgery evaluation and after recovery of
the CABG patients at 60 days. Total power for the healthy
group was higher than those for the CAD and CABG groups
(Fig. 2). HF power was similar in CABG and CAD patients
before surgery, decreased after the intervention, and recov-
ered after 30 days. LF power and the LF/HF ratio showed
increases in the first days after surgery, followed by gradual
decrements towards the pre-surgery values (Fig. 2). The
results of the CAD group remained stable throughout the 90
days of evaluation.
Respiratory function
Forced expiratory vital capacity and peak expiratory pressure
were similar in the healthy, CAD and CABG groups before sur-
gery and remained constant during the 90 days of follow-up in
the CAD group. In the CABG group, both forced expiratory
vital capacity and peak expiratory pressure decreased after
surgery and returned to pre-intervention values by 15 days
afterwards.
Discussion
The present results have shown that CABG is followed by a
depression of autonomic cardiac modulation, as demon-
strated by reduced indices of conventional autonomic bedside
tests and decreased HRV. The impaired autonomic modula-
tion reached the lowest level 3–6 days after surgery, returning
to pre-surgery values at about postoperative day (POD) 30–
60. Although previous studies have shown similar trends
[12,13], the present design employed an original approach,
combining higher temporal resolution during the first month
(PODs 3, 6, 15 and 31) with a follow-up long enough (POD
90) to detect the recovery of autonomic function to pre-sur-
gery values.
Adequate control groups have been employed previously to
evaluate the specific effect of CABG. For example, Hogue and
colleagues [13] showed that patients undergoing CABG pre-
sented HRV indices 40–50% lower than patients undergoing
nonthoracic vascular surgery, an effect that persisted for 5
days. Thus, the CABG itself reduced HRV. The work by Bron-
ner and colleagues [11] employed patients undergoing aortic
valve replacement as a specific control for patients undergo-
ing cardiac surgery due to myocardial ischemia. These authors
found that HRV decreased to similar proportions in the two
groups, suggesting that the factors common to both surgical
procedures, such as the cardiopulmonary bypass with cardio-
plegia and mechanical manipulation of the heart, were respon-
sible for impairment of the autonomic function. In the present
study, patients with CAD in similar clinical conditions to the
CABG patients but who refused surgery were studied as a
control for the surgical procedure group. As expected, the
results from the autonomic tests and HRV variability before
surgery were similar in the two groups and decreased after
surgery, but did not change in the CAD group during 90 days.
Figure 1
Longitudinal evaluation of autonomic cardiovascular tests in patients  undergoing coronary artery bypass grafting surgery Longitudinal evaluation of autonomic cardiovascular tests in patients 
undergoing coronary artery bypass grafting surgery. Longitudinal auto-
nomic cardiovascular evaluation (Valsalva maneuver and respiratory 
sinus arrhythmia) in the three groups: CABG, patients who underwent 
coronary artery bypass grafting; CAD, patients with coronary artery dis-
ease who did not undergo surgery; healthy, control subjects without 
CAD. *P < 0.05 versus CABG preoperative value; †P < 0.05 versus 
CABG day 3; ‡P < 0.05 versus CABG and CAD.Available online http://ccforum.com/content/9/2/R124
R128
In addition, both groups have shown lower values of auto-
nomic cardiac indexes in comparison with paired healthy sub-
jects, emphasizing the effects of CAD on autonomic function.
The study by Bauernschmitt and colleagues [9] also com-
pared the results from patients undergoing CABG against
those obtained from healthy volunteers, and showed that par-
asympathetic function was impaired 20 hours after surgery,
but longer periods were not evaluated. The value of HRV as a
tool for investigating autonomic function was also evaluated by
Carpeggiani and colleagues [16], who showed that the LF
spectral component has independent prognostic value early
after acute myocardial infarction to predict in-hospital
complications.
Mechanisms of autonomic alterations in CABG
Various factors related to the CABG surgery could be involved
in the impairment of cardiac autonomic modulation. Induction
of anesthesia with fentanyl–diazepam–pancuronium have
been demonstrated to decrease HRV, particularly the HF com-
ponent, therefore increasing the LF/HF ratio [17]. These
results suggest that this combination of drugs decreased
vagal modulation and increased cardiac adrenergic activity
(see below). In addition, Hogue and colleagues [13] have
shown that induction of anesthesia before cardiopulmonary
bypass surgery decreased HRV in comparison with the preop-
erative day. However, patients undergoing CABG presented a
further decrease in HRV indices, revealing that the surgery had
an effect besides that of anesthesia on autonomic function.
Several mechanisms have been suggested to impair auto-
nomic function after CABG, such as mechanical destructions
of autonomic fibers caused by aortic clamping [18,19],
although an experiment in a canine model did not show a sig-
nificant effect [20]. Extracorporal circulation could be theoret-
ically involved as mechanism, but a recent study by Demirel
and colleagues has not found a correlation between the dura-
tion of extracorporal circulation and the magnitude of auto-
nomic function [12]. In addition, other factors involved with the
surgical procedure, including cardioplegia and hypothermia,
have been speculated to cause autonomic dysfunction [20]
but have not been evaluated in a systematic manner. More
recently, autonomic modulation of heart rate has been shown
to be reduced by systemic inflammation [21], a condition
known to occur after CABG [22].
Clinical implications
The reduction of bedside tests and the time-domain indexes of
HRV observed after CABG indicate an overall impairment in
the autonomic modulation of heart rate. However, these
indexes cannot distinguish between sympathetic adrenergic
Table 2
Time-domain indexes of heart rate variability before and at various intervals after coronary artery bypass grafting
Variable Group Preoperative After surgery
3 days 6 days 15 days 30 days 60 days 90 days
Mean R–R (ms) CABG 903 ± 40 761 ± 45* 781 ± 42* 790 ± 36* 802 ± 26* 801 ± 36 802 ± 35
CAD 856 ± 49 - - - 842 ± 38 816 ± 33 835 ± 47
H e a l t h y 8 6 0  ±  3 6 ------
SDNN (ms) CABG 35 ± 3 16 ± 2* 16 ± 2* 19 ± 2* 25 ± 2* 32 ± 3 27 ± 3
CAD 31 ± 4 - - - 29 ± 3 30 ± 3 31 ± 2
Healthy 42 ± 5† ------
SDANN (ms) CABG 16 ± 3 6 ± 1* 6 ± 1* 9 ± 1* 15 ± 3 18 ± 3 14 ± 2
CAD 21 ± 4 - - - 19 ± 3 20 ± 3 20 ± 3
Healthy 39 ± 7† ------
RMSSD (ms) CABG 24 ± 4 10 ± 2* 10 ± 1* 12 ± 1* 19 ± 4 21 ± 3 19 ± 2
CAD 22 ± 3 - - - 18 ± 3 19 ± 2 20 ± 4
H e a l t h y 2 7  ±  3 ------
pNN50 (%) CABG 8 ± 0 3 ± 0* 3 ± 0* 3 ± 0* 4 ± 0* 7 ± 0 6 ± 0
CAD 4 ± 0 - - - 3 ± 0 4 ± 0 3 ± 0
Healthy 11 ± 0b ------
Values are means ± SEM. *P < 0.05 versus CABG preoperative value; †P < 0.05 versus CABG and CAD. CABG, patients who underwent 
coronary artery bypass grafting; CAD, patients with coronary artery disease who did not undergo surgery; healthy, control subjects without CAD; 
pNN50, percentage number of pairs of adjacent R–R intervals differing by more than 50 ms; RMSSD, square root of the mean of squares of 
differences between adjacent R–R intervals; SDANN, standard deviation of the averages of the R–R intervals calculated in 5-minute segments; 
SDNN, standard deviation of all R–R intervals.Critical Care    April 2005  Vol 9 No 2    Soares et al.
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and parasympathetic function. Conversely, analysis of the
power spectrum in the frequency domain has been used to
provide insights into the relative contributions of the two
branches of the autonomic nervous system to the global
behavior of HRV [6]. The HF component is determined by
vagal modulation, whereas the LF component carries the influ-
ence of both sympathetic adrenergic and parasympathetic
modulation, and the ratio between LF and HF components
should indicate sympathetic modulation, or the reciprocal rela-
tion of LF and HF components as a marker of the state of the
sympathovagal balance [6]. In the present study, RSA, Val-
salva maneuver, and time-domain indices of HRV showed pat-
terns similar to those observed in the HF power; that is, nadir
values at PODs 3–6 and recovery at about POD 30. It there-
fore seems that the HR response to the bedside tests and the
time-domain indices of HRV have parasympathetic modulation
as the major mechanism. In contrast, the LF component and
the LF/HF ratio presented the exact opposite behavior,
showing an increase after CABG with peak values at POD 6,
returning to pre-surgery values at about POD 30. This should
be interpreted as a reversible increase in the sympathetic drive
after CABG and also suggests that, at least in these patients,
the LF/HF ratio is linked mainly to adrenergic modulation.
The present results may have practical implications. Although
a previous report by McHugh and colleagues did not find a
relationship between HRV and cardiovascular instability in the
intensive care unit after cardiac surgery [23], altered heart rate
dynamics has been shown to be related to myocardial
ischemic episodes in patents after CABG [23], suggesting
that the autonomic nervous system has an important role in the
pathogenesis of myocardial ischemia in the post-operative
phase of CABG. Sympathetic activation increases cardiac
oxygen demand, causing myocardial ischemia in patients with
Figure 2
Longitudinal evaluation of heart rate variability in patients undergoing coronary artery bypass grafting surgery Longitudinal evaluation of heart rate variability in patients undergoing coronary artery bypass grafting surgery. Longitudinal results of spectral analy-
sis of heart rate variability in the three groups: CABG, patients who underwent coronary artery bypass grafting; CAD, patients with coronary artery 
disease who did not undergo surgery; healthy, control subjects without CAD. Total power (a) and low-frequency power (b) indicate both adrenergic 
and parasympathetic modulation of heart rate; high-frequency power (c) represents the parasympathetic component; and the low-frequency/high-
frequency ratio (d) represents autonomic balance that modulates heart rate. *P < 0.05 versus CABG preoperative value; †P < 0.05 versus CABG 
day 3 or 6; ‡P < 0.05 versus CABG and CAD, except high frequency, for which ‡P < 0.05 versus CAD.Available online http://ccforum.com/content/9/2/R124
R130
coronary obstruction. In addition, norepinephrine (noradrena-
line) enhances myocardial electrical excitability and can trigger
ectopic foci and ventricular arrhythmias [3]. In contrast, vagal
stimulation decreases myocardial work and oxygen demand
and is known to protect against cardiac arrhythmias acting on
electrophysiological properties of the myocardium, such as
increasing fibrillatory threshold [24,25]. Patients recovering
from CABG might therefore be at augmented risk for myocar-
dial ischemia and arrhythmias at about POD 3, when adrener-
gic influence is higher and vagal modulation is at its lowest. It
is worth noticing that RSA and Valsalva maneuver, simple
autonomic bedside tests, were able to show the impairment
and recovery of autonomic function after CABG in a similar
manner to that of HRV, which demands relatively more com-
plex analytical methods. This might facilitate the application of
autonomic evaluation after CABG in the clinical setting of a
larger number of centers.
The results of the HF component are particularly interesting in
the clinical perspective. The values for CABG patients were
lower than those for healthy controls and quite similar to
patients with CAD. After surgery there was a progressive
increase in the HF values such that after 90 days these values
were higher than those observed in CAD patients and identi-
cal to those of the healthy group. This suggests that CABG
was able to induce an increase in cardiac vagal modulation in
comparison with pre-surgery values, with potential protective
action, because there is specific interest in measures capable
of correcting parasympathetic dysfunction [26]. Similar results
were obtained by Bellwon and colleagues [10]. Future studies
should be conducted to establish whether autonomic evalua-
tion is useful in predicting clinical outcome in patients after
CABG and whether correction of vagal modulation can be
considered as a mechanism for protection in patients under-
going CABG.
Limitations of study
Because the present study involved only patients with normal
ventricular function (ejection fraction more than 50%), we can-
not extrapolate the results to other patients with poor ventricu-
lar function. In addition, the relatively small sample size,
although sufficient to detect group differences, prevented us
from exploring a potential difference between patients with
coronary lesions affecting diverse ventricular walls. This would
be an interesting aspect for exploration in future studies,
because a more pronounced autonomic impairment has previ-
ously been shown in patients with myocardial ischemia on the
anterior wall in comparison with those showing inferior wall
ischemia [27]. Given that several pharmacological agents can
interfere with autonomic function, the apparent more prevalent
use of β-blockers in the CABG group could represent a con-
founding effect. Nevertheless, the proportion of drugs used
was not statistically different, and the core analysis of the
study was the longitudinal evaluation of autonomic function of
each group, in which each subject served as his or her own
control. Another limitation of the present study is that it cannot
be determined which factors related to CABG were responsi-
ble for the autonomic changes (see above). Despite the under-
lying mechanism, it was quite clear that CABG and/or related
factors caused reversible autonomic dysfunction with poten-
tial clinical impact.
Conclusion
The results of this study show a decrease in the cardiovascular
autonomic function indexes after CABG. The lowest values
occurred 3–6 days after surgery with a gradual recovery,
returning to preoperative values by POD 60. Future investiga-
tions should verify whether these results have practical impli-
cations for predicting clinical outcome; that is, whether the
evaluation of autonomic function can detect patients with a
higher risk after CABG.
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